Enrofloxacin tablets

The Defense Logistics Agency Troop Support Medical Supply Chain solicited quotes through DIBBS for enrofloxacin tablets (NSN 6509-01-487-5834, one bottle), with quotes due November 2, 2026, so the response window has closed. The procurement is unrestricted, marked "No Set-Aside Used," and is not a small business set-aside. Delivery is to a U.S. military medical material center at WK4FV1, Kaiserslautern, Germany, within an 84-day delivery window, with FOB Destination terms and inspection at destination. The solicitation type is Fast Auto Evaluation.

The item is an FDA-regulated veterinary product, a 68 mg, 7% concentration tablet for use in dogs and cats only, supplied in bottles of 250 tablets. It requires a 36-month shelf life that is non-extendable under RS020. Packaging and marking must comply with Medical Marking Standard No. 1 and MIL-STD-2073-1E. The procurement incorporates the DLA Master Solicitation for Automated Simplified Acquisitions (Revision 105, May 20, 2026) and the DLA Technical and Quality Master List. Buy American requirements under DFARS 252.225-7001 apply, and the Berry Amendment applies with a $150,000 threshold. Payment runs through Wide Area Workflow, and hazardous material identification and safety data requirements apply.

Procurement history in the attachment shows multiple prior awards to CAGE code 4PG41 (Covetrus North America, LLC) at unit costs from $233.64 to $300.74, and one award to CAGE code 3G5T7 (Patterson Veterinary Supply, Inc.). The product classifies under PSC 6509, Drugs and Biologicals, Veterinary Use.